chrisvoncsefalvay/vaers-outcomes huggingface dataset:
A non-serious spontaneous report of swelling of right lower eyelid was received from a father concerning his 5-year-old male child subsequent to FLUMIST. The patient has no egg or milk protein allergy nor asthma. Concomitant medications were not reported for this patient. The patient had previously received 3 doses of flu vaccine with no reported adverse events. The patient received FLUMIST by nasal administration for the first time on 23-Sep-2008. On 24-Sep-2008, a reaction occurred under the patient's eye described as swelling of the right lower eyelid. As of 03-Oct-2008, the clinic where the patient received FLUMIST has not received any communication regarding the adverse event nor was the patient brought in for follow-up consultation. The right lower eyelid was still swollen as of 26-Sep-2008.
Initial report received from a healthcare professional on 29 October 2013. A 32-year-old female patient who had no illness at the time of vaccination, no medical history and concomitant medication were not reported, had received an intramuscular dose of FLUZONE, lot number, dose number were reported) in the left deltoid on 15 October 2013. On 17 October 2013, the patient had experienced soreness at injection site, 2 days later sudden onset of pain in the left shoulder, clavicular area but a little more medial. The symptoms were progressed and patient had burning pain and numbness in the nerve distribution of the left arm. It was reported that the brachial plexus is affected and symptoms were continue to worsen. Corrective medications were not reported. At the time of this report, the patient had not recovered from events. Documents held by sender: None. Additional information received on 29-Oct-2013: Subsequent Magnetic resonance imaging (MRI) shows herniated nucleus pulposus (HNP) C5-6. Follow up information was received on 18 December 2013. At the time of report outcome of the event was recovered.
Information has been received from a physician concerning his niece who was vaccinated  with a dose of hepatitis B virus vaccine rHBsAg (yeast). Subsequently the pt experienced an event. The reporter refused to disclose what the event was. It was unknown if medical attention was sought. There was no product quality complaint. No additional information is expected.
2 hours after receiving SHINGRIX shot, my left arm began throbbing and the pain was unbearable. The pain and throbbing lasted for 4 days, during which time I sat with ice packs on my arm. After 4 days the pain began to gradually subside, yet it still hurt to move or raise my arm. Even after a month has passed since the shot, it still hurts when I raise my left arm to shoulder height. I spoke to the pharmacist and told him of my adverse reaction. He told me he had received similar complaints. He advised me not to get the 2nd injection. I'm still unsure of what to do about this. I certainly don't want to go through the pain and misery a 2nd time, yet I want to be protected from shingles.
pt recvd vax JUN92 & devel burning sensation upon injection as well as soreness & or an aching sensation in the arm; heaviness in the arm;
"Typical bad reactions"; Low grade fever; General fatigue; Received 50mcg IM injection (Half dose); 3rd dose received after 28 days of second dose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION ("Typical bad reactions"), PYREXIA (Low grade fever), FATIGUE (General fatigue), ACCIDENTAL UNDERDOSE (Received 50mcg IM injection (Half dose)) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (3rd dose received after 28 days of second dose) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 8520100102) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 50 microgram. On 28-Jan-2021, the patient experienced VACCINATION COMPLICATION ("Typical bad reactions"), PYREXIA (Low grade fever), FATIGUE (General fatigue), ACCIDENTAL UNDERDOSE (Received 50mcg IM injection (Half dose)) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (3rd dose received after 28 days of second dose). On 28-Jan-2021, ACCIDENTAL UNDERDOSE (Received 50mcg IM injection (Half dose)) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (3rd dose received after 28 days of second dose) had resolved. On 29-Jan-2021, VACCINATION COMPLICATION ("Typical bad reactions"), PYREXIA (Low grade fever) and FATIGUE (General fatigue) had resolved.            The consumer reported that he received a third booster dose, 50 mcg, of Moderna vaccine on 28Jan2021 and experienced the typical bad reactions, including low grade fever and general fatigue. He reported that the events lasted for 24 hours and resolved.  No concomitant product use was provided by the reporter.   No treatment medications were reported.  The consumer stated that he was in the Moderna COVID-19 Phase 2 Clinical Trials.  He stated that he was unblinded and did receive the actual Moderna COVID-19 vaccine and not the placebo. He stated that he received the first Moderna COVID-19 dose on 26 June 2020.  He also stated that the intramuscular injection of dose 100 mcg was given into his left deltoid and lot number was 8520100102.  The consumer stated he didn't experienced any adverse events after the first dose.   The consumer reported that he received the second Moderna COVID-19 dose on 29 July 2021. He stated that he was given 100 mcg dose into the left deltoid, intramuscularly, and lot number was 8520100103. The consumer reported that after the second dose he experienced the typical bad reactions, including low grade fever and general fatigue.  The consumer reported that the events lasted for 24 hours and resolved.    The consumer reported that he was perfectly healthy and does not use any medications daily. He also stated that he probably gave blood 12 times during the clinical trial.   Most recent FOLLOW-UP information incorporated above includes: On 26-Aug-2021: Follow up received includes added Patient's race,  Second dose start date.
swollen lymph areas - armpit area, elbows, knees. aching joints / shoulders, elbows, wrists, knees; Aching lymph areas - armpit area, elbows, knees. aching joints / shoulders, elbows, wrists, knees; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the right arm on 23Apr2021 at 15:30 (at the age of 48-years-old), as a single dose for COVID-19 immunisation. Medical history included some insect bites. Concomitant medications were not provided. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the right arm on 02Apr2021 at 15:00 (at the age of 48-years-old), as a single dose for COVID-19 immunisation. The patient previously took oak and pine on an unknown date for unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02May2021, the patient experienced swollen and aching lymph areas - armpit area, elbows, knees. aching joints / shoulders, elbows, wrists, knees. The clinical outcome of the events swollen and aching lymph areas - armpit area, elbows, knees. aching joints / shoulders, elbows, wrists, knees were not resolved at the time of reporting.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
This spontaneous report has been received from a medical assistance via company representative referring to multiple patients of unknown demographics. Information regarding the patients' medical history, current conditions, drug and allergy history and concomitant therapies were not provided. On an unknown date the patients were vaccinated with GARDASIL 9 injection, intramuscularly (dose, anatomical location, lot number and expiration date were not provided) for Human Papilloma Virus (HPV). It was reported that on an unknown date, after GARDASIL 9 vaccination, the patients fainted at standing up after being sitting for 30 minutes. The patients, outcome was unknown at the reporting time. The causality between the event and therapy with GARDASIL 9 was unknown. Additional information has been requested.
She received vaccination at 1430 hrs on April 2.  Died in her sleep that night...sometime between 2200 hrs April 2 and 0600 hrs April 3.
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE NON ST ELEVATION MI 10/21/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Case number PHEH2013US024967, is an initial spontaneous report from a physician received on 25 Nov 2013 with the follow-up received on 07 Jan 2014. This report refers to a 62-year-old male patient. His medical history included coronary artery disease, sleep apnea, hypercholesterolemia, asthma, shoulder pain right, right knee pain, abnormal weight gain, hypertension, herpes labialis, peripheral edema, lung nodule found during imaging, rotator cuff tear, tonsillectomy, bypass surgery, tumor removed from bladder, partial prostatectomy and aortic valve replacement. He was a social alcohol user (3 times a month). His family history included father deceased at 76 years due to heart disease and esophageal cancer and mother deceased at 78 years due to colon carcinoma. Concomitant medication included long term use of anticoagulant. He was vaccinated with FLUVIRIN (batch number: 1309801, expiry date: May 2014) inadvertently one dose from opened and unopened MDVs that were stored below the recommended mentioned temperature, at a dose of 0.5 ml intramuscularly into left deltoid on 20 Nov 2013 at 15:54. The reporter stated that, the vaccine was not frozen upon administration and was unsure if the vaccine had frozen during the temperature excursion. It was reported that, FLUVIRIN was opened and unopened MDVs reached 32 Fahrenheit (F) at 6 hours on 14 Nov 2013 and 16 Nov 2013. On 17 Nov 2013, it reached for 31 F for 6 hours. No more information was available. Follow-up received from physician on 07 Jan 2014: Updated patient demographics, medical history, family history, concomitant medications, site and time of vaccine administration.
Moderna COVID-19 Vaccine EUA.  On early morning of 04/02/2021 arm became very discolored (mostly bright red/scarlet color) between elbow and just below vaccination injection site.  Through the course of the weekend arm became worse but the initial pain changed to irritation/itching primarily.  On 04/05/2021 at 6 a.m. upon wakening arm was still vividly discolored but my blood pressure reading first thing was high (197/99 with a 90 pulse) which is very unusual for me now.  Not only that but I also experience at same time a nose bleed.  Since other than assuming in general that the arm discoloration connected somehow to the vaccination I had no idea if the spike in BP also connected and the nose bleed (since I rarely have any nose bleeds) I went to the ER - which is a small county hospitals about 3 miles from my home.  I did not attempt to take a Clonidine at home before going there as I wanted them to see if there was a connection between these 3 issues.  Upon arrival my blood pressure was taken again and it was the same high numbers as  at home not long before.  The ER doctor on duty that morning unfortunately didn't seem to  know what might be wrong with my arm and so she focused on bringing down my blood pressure by instructing a nurse to give me a Clonidine.  Within about a half hour when my BP had returned to normal they dismissed me to go home without any actual information as to whether the 3 issues were connected of not and without obviously having a clue as to what the situation was with my arm.   During the course of the day my daughter did some research on the internet and determined that it must be 'COVID Arm' that I was suffering from.  First thing the next morning (04/03/21) I called my GP doctor's office to try to get an appointment but unfortunately he was fully booked and so instead I called the the local Health Department and spoke with one of the nurses who works in their COVID Vaccination program.  On telling her of my experiences she confirmed that it sounded very much like COVID Arm.
on 04/29/2021 Resident was checked at 1830 and found to be at baseline status.  At approximately 1855, resident was found pulses and apneic.  CPR initiated and resident transferred to medical center. Resident expired 1939.
Pt recv vax on 11/20/98; on same day pt exp red rx on LA to upper chest, vomiting, dizzy
This spontaneous report has been received from a Nurse, concerning a 72 year old patient of unknown gender. The patient's medical history, concurrent condition and concomitant medication were not provided. On an unknown date in 2016 (reported as "last year", the patient was vaccinated with a dose of PREVNAR 13 (dose, strength, route of administration were not provided) for prophylaxis. Then approximately in April 2017 (reported as within the last month), the patient was vaccinated with a dose of PNEUMOVAX23, intramuscular, lot # reported as N0039997 and expiration date of 20-OCT-2018 (dose and frequency were not provided) for prophylaxis. In April 2017, the patient experienced blood red areas around the arm (erythema), swollen, warm to touch, nothing at the injection site. The patient was treated with MEDROL dose pack and ATARAX as also experienced itching. It was unknown by the reporter if laboratories studies were performed. The patient was recovering from these events on an unknown date in April 2017. However, in April 2017, the patient died. It was unknown whether an autopsy was performed. The patient's cause of death was not provided. The causal relationship between the therapy with PNEUMOVAX23 and the events of blood red areas around the arm, swollen, warm to touch, itching and death was not reported. Upon internal review the patient's death was considered medically significant. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513 -1704USA013548: US-009507513 -1705USA004705.
Began experiencing dizziness 2 days after shot.  Dizziness is more severe when laying down.  Also feels like inner ears are sore.  Experiencing ringing in ears as well.  This has lasted for almost 4 weeks.  Dizziness is a bit better, but still experiencing pressure and ringing in ears.   Tried using nasal sprays and allergy medicine to help alleviate symptoms.  Doesn?t help.
I have gotten a rash on both of my lower legs; it itches quite badly; This is a spontaneous report from a contactable consumer or other non-healthcare professional. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: Unknown), via an unspecified route of administration, on unspecified date, as dose 2, single for COVID-19 immunization and also received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: Unknown), via an unspecified route of administration, on unspecified date, as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced i have gotten a rash on both of my lower legs, it itches quite badly. The events resulted physician office visit. Therapeutic measures were taken with an ointment at 45.00 a tube that has helped decrease the itching over a weeks time. The clinical outcome of event i have gotten a rash on both of my lower legs was unknown and it itches quite badly was resolving.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
immediately following injection patient stated became slightly dizzy and brief chest pain. Patient was told o lay down and vital signs were check. VS were normal both times. Patient never lost consciousness, able to converse in full sentences. Was able to drink 4 oz water. After 30 minutes symptoms completely resolved. Patient states gets anxious with injections normally.
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and genders. The reporter stated that, on an unspecified date, an unknown number of doses of PEDVAXHIB (dose, lot#, expiration dates not provided) that were stored at 48 degrees F for 20 minutes, then exposed to 47 degrees for 9 minutes have been administered. No adverse effects were reported. Follow up information has been received on 22-JUL-2014 from a receptionist. The reporter stated that there were two different lot numbers of PEDVAXHIB that were included in the temperature excursion: Lot # J016188, expiration date: 02-OCT-2016 and lot # J015437, expiration date: 09-OCT-2016. The receptionist did not have any additional information to share with Merck. Follow-up information has been received from the registered nurse who provided patients details. This report refers to a 10 weeks old infant patient of unknown gender. On 11-JUN-2014 the patient was vaccinated with a dose of PEDVAXHIB (dose and route were not reported, lot# J015437, expiration date: 09-OCT-2016) that was improperly stored. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information is not expected.
No discomfort immediately after vaccine given. Noticed the next morning an intermittent shooting pain in right shoulder. States up to a "5-6" on pain scale. Reported to occupational health but was instructed to follow up with PCP.  When he saw his PCP, PCP told him to report to Occ. Health. 10/12/18 again reported to occ. health same intermittent pain. Referred back to PCP as this is not something occupational health can assess or treat.
After you having the vaccine, she experienced soreness which continued to redden, swell and get very hot to the touch and was feeling sick and went to bed early.  The swelling was moving down her arm. She called the pharmacy, and was instructed to take Benadryl every 4 to 6 hours. The swelling went down to about 4 inches from her wrist and had two red lines coming from under her arm. On Monday, called the doctor's office and saw with the P.A. which diagnosed her with lymphangitis.  was given doxycycline by the P.A.
pulmonary embolism; Blood Clot; This is a spontaneous report from a contactable consumer (patient). A 59-yearold male patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 07Apr2021 (Batch/Lot Number: ew0153) as 1st dose, single (at the age of 59 years) for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient has not had covid-19 prior to vaccination. The patient experienced pulmonary embolism on an unspecified date and blood clot on 22Apr2021 with outcome of not recovered. The patient was hospitalized for blood clot for 2 days. The patient underwent lab tests and procedures which included blood test: negative  on 26Apr2021. Therapeutic measures were taken as a result of the events incudes blood thinner. The outcome of the event blood clot was not recovered  and unknown outcome for the event pulmonary embolism. The patient was tested negative for Covid-19 on 23Apr2021 (post vaccination).  No follow-up attempts are possible; information about batch number already obtained.
Running temperature; Diarrhea; sore arm, arm really hurts; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Running temperature), DIARRHOEA (Diarrhea) and PAIN IN EXTREMITY (sore arm, arm really hurts) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Running temperature), DIARRHOEA (Diarrhea) and PAIN IN EXTREMITY (sore arm, arm really hurts). At the time of the report, PYREXIA (Running temperature), DIARRHOEA (Diarrhea) and PAIN IN EXTREMITY (sore arm, arm really hurts) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were provided by reporter. No treatment was reported.   Reporter did not allow further contact
This spontaneous report as received from a pharmacist refers to a patient. The pharmacist reports that the patient received a dose of 0.5 ml ZOSTAVAX injection subcutaneously "four years ago" in 2009 when the patient was 34 years old. The patient states that she took the ZOSTAVAX to treat a chronic dermatologic type disorder (name of disorder unspecified). The patient stated that the ZOSTAVAX improved the symptoms of that condition. Patient had sought medical attention by office visit. Additional information has been requested.
PT HAS SWOLLEN AND RED ARM, SHOULDER TO ELBOW. PT STATES NOT WARM TO TOUCH OR PAINFUL, EXCEPT WHEN LYING DOWN TO SLEEP ON IT. TIGHT ELBOW FROM SWELLING. RED AREA SEEMS TO BE SPREADING, EVEN 3 DAYS LATER. PT FEELS OK OTHERWISE, JUST SEEKING ADVICE ON IF MEDICAL CARE IS NECESSARY FOR THIS RED AREA SPREADING 3 DAYS LATER. I ADVISED PT TO CONTINUE MONITORING, LOCALIZED REACTION SHOULD BEGIN TO RESOLVE AND IMPROVE MOVING FORWARD. ICE PACKS, BENADRYL, AND IBU WERE RECOMMENDED TO HELP WITH THE SWELLING AND TIGHTNESS HE'S EXPERIENCING.
PATIENT WIFE NOTICED A RED UNRAISED MARK TO BACK OF RT ARM, WARM TO TOUCH, NO FEVER, CHILLS, NAUSEA, VOMITING, HA, DIARRHEA, FULL R.O.M., NO DIFFICULTY BREATHING OR CHEST PAIN.
given their second shots 2 WEEKS after their first; This case was reported by a consumer and described the occurrence of drug dose administration interval too short in a adult male patient who received Herpes zoster (Shingrix) for prophylaxis.   Concomitant products included Herpes zoster (Shingrix).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix and an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too short. On an unknown date, the outcome of the drug dose administration interval too short was unknown.  Additional details were provided as follows: The patient was reporter sister's husband. The age at vaccination was not reported. The patient had taken second shot two weeks after first shot and not properly immunized, which led to which led to shortening of vaccination schedule. No further information was provided. This case has been linked with case US2021AMR087434 by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR087434:same reporter
11:00 complained of being lightheaded; flushed; hot; heart pounding. 11:15 symptoms eased. 11:20 lightheaded again. 11:30 back to baseline.
Since receiving my first Pfizer Covid shot in my left arm in May 2021, I have experienced continuous, painful (pins & needles) and unbearable burning and itching on BOTH of my arms, mostly my forearms.  I have a constant red rash with itching that never subsides, day or night.  It's difficult to sleep at night.  I have tried to put aloe vera ointment on them, various over-the-counter creams and nothing helps to relieve  the pain to any real degree.  The second shot weeks later made it even worse.  Lately, I need to take a Benadryl every night just to be able to sleep but the minute I wake up...the rash, pain in my arms, itching starts all over again.  I hate this!  This "vaccine" has ruined the quality of my life.  I wish I had never gotten this untested, unapproved "vaccine."  I will NOT be taking any booster shots and the government better not force me to with mandates.  I keep hoping this crazy experimental "vaccine" wears off and I can have my life back.  We are not guinea pigs.  This whole thing needs to end until the appropriate tests have been studied carefully.  I have not been to the doctor for my rash because what will they do?